-
J Crohn's and Colitis: Gut microbes predict the effectiveness of enteritis medication
Time of Update: 2021-03-04
study showed that the gut bacteriosty of patients with inflammatory bowel disease differed in several bacterial and fungal genus before treatment.
-
AP-T: Analysis of the efficacy of hyperbaric oxygen therapy in 20 cases of Crohn's disease
Time of Update: 2021-02-26
the authors of this study found significant clinical, radiological and biochemical improvements in crohn's disease patients with resuscable fistula after hyperbaric oxygen therapy.
-
AP-T: Compared to endoscopic mucosa healing in Crohn's disease, intestinal permeable wall healing
Time of Update: 2021-02-26
and permeable wall therapy of 51.9% (80/154), 10.4% (16/154), 19.5% (30/154) and 18.2% (28/154) cures, respectively. the risk of intestinal damage is lower than that of permeable wall healing (HR s 0.05 s 0.00-0.40, P s 0.002) and MRI healing (HR s
-
DCR: Safety analysis of complex fistulas that are not related to Crohn's disease in the treatment of interstate-charged stem cells of isometric adipose tissues
Time of Update: 2021-02-24
, the purpose of this study was to assess the safety of allogeneic interstumogenous stem cells in treating complex fistulas in patients without Crohn's disease.
-
IBD: Passive smoking increases the risk of intestinal surgery in patients with Crohn's disease
Time of Update: 2021-02-23
to assess the impact of exposure to passive smoking on the risk of intestinal surgery, only patients who had never smoked were included.
-
Cell Host Microbe: Study finds Achilles heel of Crohn's disease-related bacteria
Time of Update: 2021-02-23
Adhesive invasive E. coli is used to convert by-products of sugar fermentation to grow in the intestines. specifically, adhesive invasive E. coli uses 1,2-propylene glycol, a by-product of the breakdown of sugar called algal sugar, which
-
TAG: Use plateplate and lymphocyte ratios in blood routines to predict disease activity in crohn's disease patients
Time of Update: 2021-02-23
simple endoscopic score of CDs, CBC parameters, C-reactive protein (CRP) levels, individual variable rates of red blood cell sedation, and fecal calcitonin (FC) were analyzed independently by different researchers.
-
AbbVie IL-23 inhibitors have been approved in China for clinically targeting Crohn's disease
Time of Update: 2021-02-10
it's worth noting that AbbVie recently announced that risankizumab has reached the primary endpoint of the induction phase in two Phase 3 clinical trials for adult patients with moderate to severe Crohn's disease.
-
AbbVie IL-23 inhibitors have been approved in China for clinically targeting Crohn's disease
Time of Update: 2021-02-10
It's worth noting that AbbVie recently announced that risankizumab has reached the primary endpoint of the induction phase in two Phase 3 clinical trials for adult patients with moderate to severe Crohn's disease.
-
Clin Gastroenterology H: Persistent diarrhea in patients with Crohn's disease with mucous membrane
Time of Update: 2021-01-23
endoscopy showed no significant difference between the diversity of tissue-related microbiomes and the control group after an improvement in mucous membrane inflammation in UC or IBD-U patients.
-
segments in patients with gastrointestinal colon Crohn's disease
Time of Update: 2021-01-22
, the study looked at differences in endoscopic MH in different colon segments in CD patients treated with IFX.
-
TAG: Plateplate-to-lymphocyte percentage index is a simple non-invasive tool for monitoring endoscopic activity in Crohn's disease
Time of Update: 2021-01-22
Crohn's disease (CD) is a chronic gastrointestinal inflammatory disease characterized by relapse and remission. about half of CD patients have intestinal complications, such as stenosis or fistula. , close monitoring of disease activity
-
AJG: The location, not severity, of the disease can affect the endoscopic remission rate of Crohn's disease
Time of Update: 2021-01-22
in this study. a colonoscopy at weeks 0, 12 and 54 of treatment to assess changes in the condition. endoscopic healing is defined as the absence of ulcers and complete endoscopic remission, and the CD endoscopic severity index (CDEIS)
-
Clin Gastroenterology H: Reducing the duration of use of Usnu monoantigen can improve the effectiveness of treatment for Crohn's disease
Time of Update: 2021-01-15
the study, researchers confirmed that reducing the interval between usanu monoantigens to four weeks for non-responsive CD patients at 90 mg per 8 weeks could improve clinical and biological indicators of disease activity.
-
with endoscopic and bio-chemical remission in patients with Crohn's disease
Time of Update: 2021-01-15
the relationship between the serum concentration of usthabyn resistance during the two-week treatment and endoscopic and bio-chemical remission in patients with CD. In this forward-looking observational study, due to endoscopic markers of active CDs
-
AP-T: Risk analysis of follow-up surgery at the matching site after the right half colonectomy in patients with Crohn's disease
Time of Update: 2020-12-22
although the proportion of CD surgery has declined over time, the rate of CD diagnosis remains high in 50 per cent of patients with a removal within 10 years, with a lifetime risk of more than 70 per cent.
-
Microbiome: Fecal microbiome transplantation maintains the relief of Crohn's disease
Time of Update: 2020-12-16
once the patient enters clinical remission, the patient receives FMT or a false transplant at random during colonoscopy.
-
TAG: Compared with the Montreal classification, the classification of Crohn's disease patients
Time of Update: 2020-12-16
study aims to explore the relationship between this colon-based classification and clinical outcomes in CD patients compared to the Montreal classification.
-
JCC: Curcubin in turmeric can improve the symptoms of Crohn's disease
Time of Update: 2020-12-16
in the digestive tract. causes of CDs are not yet fully known and there is no cure. therefore, the purpose of current drug therapy is to control inflammation or prevent its deterioration. drugs include anti-tumor necrotic factor (TNF)-α
-
JCC: Early endoscopic recurrence of Crohn's disease is characterized by significantly different microbiomes
Time of Update: 2020-12-14
study looked forward to the composition of feces and mucous membrane microorganisms after re-blind bowel excision to determine the predicted value of the microbiome associated with recurrence.
